Teladoc Health Inc (NYSE: TDOC) has experienced a rise in its stock price by 2.12 compared to its previous closing price of 10.40. However, the company has seen a gain of 15.31% in its stock price over the last five trading days. globenewswire.com reported 2024-11-21 that PURCHASE, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the 36th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 3, 2024, at 12:30 p.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/.
Is It Worth Investing in Teladoc Health Inc (NYSE: TDOC) Right Now?
The 36-month beta value for TDOC is at 0.92. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 4 rating it as “overweight,” 19 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TDOC is 168.52M, and currently, shorts hold a 15.98% of that float. The average trading volume for TDOC on November 25, 2024 was 5.62M shares.
TDOC’s Market Performance
TDOC stock saw an increase of 15.31% in the past week, with a monthly gain of 23.49% and a quarterly increase of 45.28%. The volatility ratio for the week is 6.92%, and the volatility levels for the last 30 days are 7.10% for Teladoc Health Inc (TDOC). The simple moving average for the past 20 days is 13.81% for TDOC’s stock, with a -3.88% simple moving average for the past 200 days.
Analysts’ Opinion of TDOC
Many brokerage firms have already submitted their reports for TDOC stocks, with Goldman repeating the rating for TDOC by listing it as a “Buy.” The predicted price for TDOC in the upcoming period, according to Goldman is $14 based on the research report published on November 15, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $10, previously predicting the price at $8. The rating they have provided for TDOC stocks is “Hold” according to the report published on September 17th, 2024.
Cantor Fitzgerald gave a rating of “Overweight” to TDOC, setting the target price at $22 in the report published on February 29th of the current year.
TDOC Trading at 16.63% from the 50-Day Moving Average
After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -52.88% of loss for the given period.
Volatility was left at 7.10%, however, over the last 30 days, the volatility rate increased by 6.92%, as shares surge +23.92% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +31.27% upper at present.
During the last 5 trading sessions, TDOC rose by +15.31%, which changed the moving average for the period of 200-days by -47.89% in comparison to the 20-day moving average, which settled at $9.33. In addition, Teladoc Health Inc saw -50.72% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TDOC starting from Verstraete Stephany, who proposed sale 75,463 shares at the price of $8.92 back on Nov 19 ’24. After this action, Verstraete Stephany now owns shares of Teladoc Health Inc, valued at $673,130 using the latest closing price.
Geshuri Arnnon, the Former Officer of Teladoc Health Inc, proposed sale 34,456 shares at $9.21 during a trade that took place back on Nov 15 ’24, which means that Geshuri Arnnon is holding shares at $317,512 based on the most recent closing price.
Stock Fundamentals for TDOC
Current profitability levels for the company are sitting at:
- -0.1 for the present operating margin
- 0.63 for the gross margin
The net margin for Teladoc Health Inc stands at -0.38. The total capital return value is set at -0.1. Equity return is now at value -51.65, with -24.99 for asset returns.
Based on Teladoc Health Inc (TDOC), the company’s capital structure generated 0.51 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 1.02. The interest coverage ratio of the stock is -8.21.
Currently, EBITDA for the company is 154.0 million with net debt to EBITDA at -0.62. When we switch over and look at the enterprise to sales, we see a ratio of 0.84. The receivables turnover for the company is 11.58for trailing twelve months and the total asset turnover is 0.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.69.
Conclusion
In conclusion, Teladoc Health Inc (TDOC) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
